HLTH: The New Era of Funding Innovation in Women’s Health

Tuesday, October 21, 2025

Time: 2:40 PM - 3:10 PM

Main Stage

This is a story about what happens when life sciences leaders and experienced fund managers with billions under management decide to come together to systematically change how women's health innovation is funded. Conceptualized in partnership with industry heavyweights, this innovative approach aims to activate capital allocation into a space that has been historically under-recognized, under-funded, and under-prioritized to the detriment of half the population. The economic case is staggering: McKinsey Health Institute research shows that closing the women's health gap could regain 75 million years of lost life and unlock at least a $1 trillion annual global economic opportunity by 2040. This isn't charity or impact investing for good PR, it's experienced investors recognizing that the women's health market represents one of the largest untapped opportunities in healthcare, with fundamental gaps in medical knowledge creating white space for innovation that could generate both significant returns and transformative health outcomes. READ MORE

Jessica Federer

Managing Director, The Women's Health Fund

Tracy Warren

Sr Managing Director, Go Red for Women Fund, AHA Ventures

Dr Basmah Safdar, MD

Director, Women's Health Research at Yale

Dr Lucy Perez, PhD

Senior Partner & Global Leader, McKinsey Health Institute

Previous
Previous

Femtech Insider Article

Next
Next

The Women’s Health Fund Announced by Industry Leaders to Build the Market